Trial reportDiabetes, obesity & metabolism2025
Digitally enhanced ketogenic diet versus low-fat diet for cardio-renal-metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial.
Trial report in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Digitally enhanced ketogenic diet versus low-fat diet for cardio-renal-metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial.Diabetes, obesity & metabolism · 2025Trial
- Human-in-the-loop AI predictive digital twin to extend virtual precision diabetes care between visits.npj health systems · 2026Article
- Ketogenic Diet in Obesity and Diabetes: A Narrative Review.Nutrients · 2026Review
- Weight-adjusted waist index outperforms other obesity indices for cardiovascular disease prediction in cardiovascular-kidney-metabolic syndrome: insights from UK biobank.BMC public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimsIndividuals respond differently to diets for weight loss and cardio-renal-metabolic health. Advances in digital health and metabolomics hold promise for personalised lifestyle interventions. The study evaluated the feasibility and the preliminary efficacy of a digitally enhanced ketogenic diet compared with a low-fat diet, and explored the potential to use metabolites to guide personalised lifestyle interventions via digital health tools. MATERIALS AND
methodsThe study randomised 60 adults living with overweight or obesity to a ketogenic diet (n = 30) or a low-fat diet (n = 30). Both groups received digital lifestyle interventions, including digitally delivered education sessions, mobile and wearable devices to monitor lifestyle behaviour and health indicators, and weekly individualised feedback through digital communication platforms. Clinical outcomes (e.g., weight, blood pressure (BP), HbA1c) and targeted metabolites were collected at baseline, 3 and 6 months. Intention-to-treat analysis and linear mixed models were used to assess group and time differences.
resultsThe study successfully enrolled the planned sample size (N = 60) within 1 year despite COVID-19-related challenges. Retention rates were 73.3% at 3 months and 71.7% at 6 months. Participants were 58.3% Hispanic. No significant differences in clinical or metabolic outcomes were observed between the groups, except that the ketogenic group had significantly higher ketone levels than the low-fat group at 3 months (b = 0.2, 95% CI = [0.05, 0.35], p = 0.015). Both groups showed significant weight and Body Mass Index reductions at 3 and 6 months. HbA1c improved only in the ketogenic group (baseline: 6.0 ± 0.9%; 3-month: 5.5 ± 0.7%, p < 0.001; 6-month: 5.7 ± 0.8%, p = 0.004), and systolic blood pressure (BP) improved in the ketogenic group at 3 months (131.2 ± 12.9 to 123.1 ± 11.2, p = 0.006). Most targeted metabolites (e.g., isoleucine, leucine) decreased significantly from baseline to 3- (~21/29 metabolites) and 6-month (~22/29 metabolites) within both groups.
conclusionsDigitally enhanced lifestyle intervention was feasible. Both diets, enhanced by digital tools, were efficacious in weight reduction. The ketogenic diet showed potential benefits for glycaemic and BP control. Metabolite changes reflect sensitive responses to lifestyle interventions. Further research is warranted to explore the integration of digital tools and metabolic data for developing personalised lifestyle interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.